LAUSR

Uncertainty brings fear and, without a doubt, the emergence of the SARS-CoV-2 virus and the ongoing COVID-19 pandemic have left the public divided and healthcare systems strained [1]. Although this contagious virus is a novel strain to humans, the diligent international collaboration of the scientific community has led to significant strides in understanding it. With the concerted scientific effort to prevent this disease and control the pandemic, several vaccines such as the mRNA (BNT162b2 and mRNA-1273) and adenovirus vector (ChAdOx1 nCoV-19 and Ad26.COV.S) vaccines came to fruition expeditiously and, after significant rigorous analysis, have been given emergency use or full approval by the UK Medicines and Healthcare products Regulatory Agency (MHRA), the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) and the Australian Therapeutic Goods Administration (TGA).